NVS Novartis AG

  1. Stocks
  2. Healthcare
  3. NYSE: NVS

Price (delayed)

$97.44

Market cap

$198.82B

P/E Ratio

13.15

Dividend/share

$3.78

EPS

$7.41

Enterprise value

$216.63B

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world ...

Highlights
The company's EPS has surged by 126% YoY and by 3.6% QoQ
The company's net income has surged by 117% YoY and by 2.7% QoQ
The company's debt fell by 7% YoY but it rose by 3.2% QoQ
The quick ratio is down by 27% since the previous quarter and by 13% year-on-year
The company's equity fell by 24% YoY and by 15% QoQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: https://www.novartis.com/
Peers: PFE MRK JNJ TEVA

Key stats

What are the main financial stats of NVS
Market
Shares outstanding
2.04B
Market cap
$198.82B
Enterprise value
$216.63B
Valuations
Price to earnings (P/E)
13.15
Price to book (P/B)
5.02
Price to sales (P/S)
3.99
EV/EBIT
12.89
EV/EBITDA
N/A
EV/Sales
4.34
Earnings
Revenue
$49.92B
EBIT
$16.8B
EBITDA
N/A
Free cash flow
$12.92B
Per share
EPS
$7.41
Free cash flow per share
$6.32
Book value per share
$19.41
Revenue per share
$24.42
TBVPS
$22.02
Balance sheet
Total assets
$94.33B
Total liabilities
$54.58B
Debt
$27.28B
Equity
$39.68B
Working capital
-$2.84B
Liquidity
Debt to equity
0.69
Current ratio
0.9
Quick ratio
0.6
Net debt/EBITDA
N/A
Margins
EBITDA margin
N/A
Gross margin
72.8%
Net margin
30.5%
Operating margin
21.3%
Efficiency
Return on assets
14.6%
Return on equity
34.6%
Return on invested capital
49.4%
Return on capital employed
25.8%
Return on sales
33.7%
Dividend
Dividend yield
3.88%
DPS
$3.78
Payout ratio
51%

NVS stock price

How has the Novartis AG stock price performed over time
Intraday
-1.64%
1 week
3.26%
1 month
2.28%
1 year
-4.97%
YTD
-3.5%
QTD
0.73%

Financial performance

How have Novartis AG's revenue and profit performed over time
Revenue
$49.92B
Gross profit
$36.35B
Operating income
$10.64B
Net income
$15.25B
Gross margin
72.8%
Net margin
30.5%
The company's net income has surged by 117% YoY and by 2.7% QoQ
The company's net margin has surged by 99% YoY but it fell by 4.1% QoQ
NVS's operating income is up by 26% year-on-year and by 9% since the previous quarter
NVS's operating margin is up by 16% year-on-year

Growth

What is Novartis AG's growth rate over time

Valuation

What is Novartis AG stock price valuation
NVS P/E details
P/E
13.15
P/B
5.02
P/S
3.99
EV/EBIT
12.89
EV/EBITDA
N/A
EV/Sales
4.34
The company's EPS has surged by 126% YoY and by 3.6% QoQ
The stock's P/E is 36% less than its last 4 quarters average of 20.6 and 32% less than its 5-year quarterly average of 19.4
NVS's P/B is 32% above its 5-year quarterly average of 3.8 and 4.6% above its last 4 quarters average of 4.8
The company's equity fell by 24% YoY and by 15% QoQ
Novartis AG's revenue has increased by 9% YoY and by 7% QoQ
The P/S is 7% less than the last 4 quarters average of 4.3 and 5% less than the 5-year quarterly average of 4.2

Efficiency

How efficient is Novartis AG business performance
NVS's ROE has soared by 188% YoY and by 10% QoQ
The ROIC has soared by 168% year-on-year and by 8% since the previous quarter
Novartis AG's ROA has soared by 143% YoY and by 7% from the previous quarter
The company's return on sales has surged by 70% YoY but it fell by 3.2% QoQ

Dividends

What is NVS's dividend history
Dividend details
DPS
$3.78
Dividend yield
3.88%
Payout ratio
51%
Recent dividends

Financial health

How did Novartis AG financials performed over time
NVS's total assets is 73% greater than its total liabilities
The quick ratio is down by 27% since the previous quarter and by 13% year-on-year
Novartis AG's current ratio has decreased by 22% QoQ and by 14% YoY
The company's debt is 31% lower than its equity
The company's equity fell by 24% YoY and by 15% QoQ
The debt to equity has grown by 23% YoY and by 21% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.